#CoronaVac

Johannesburg, Sep 10 (PTI) South Africa on Friday joined the international Phase 3 clinical trials of China's Sinovac Biotech COVID-19 vaccine for those aged between 6 months and 17 years, with ...

.Beijing, China
The study was conducted in Hong Kong and assessed the risk of the adverse event within 42 days of vaccination. (Photo Credit: Representational/Unsplash)

  • "Our findings suggest an overall increase in risk of Bell’s palsy after CoronaVac vaccination," the study said
  • The benefits of the vaccine far outweigh the risks, the study published in The Lanclet journal said
  • 28 cases of Bell’s Palsy , were found among nearly 452,000 persons who received a first dose of the vaccine

Beijing, Aug 17 (PTI) The beneficial effects of COVID-19 vaccines far outweigh the risk of facial paralysis on one side of the face known as Bell's Palsy, confirms a large-scale population-based ...

Southampton, Jul 26 (The Conversation) China’s vaccine-development system has been busy during the pandemic. Two Chinese vaccines are now being used around the world: the Sinopharm vaccine and ...

.Brazil, IN, USA
CoronaVac was approved by the World Health Organization for emergency use in June.(Photo credit: Twitter/@FranAlabi)

  • Two doses of the China-made COVID-19 vaccine, CoronaVac, is less effective against the Gamma variant
  • The antibodies work less against the variant than the previous COVID strain
  • Gamma may also be able to reinfect people who previously have the virus

.Beijing, China
The World Health Organisation granted Emergency Use Listing to the Chinese vaccine (Representational/ Unsplash)

  • Two doses of the China-made COVID-19 vaccine, CoronaVac, are effective in children and adolescents aged 3-17 years
  • Research found that the vaccine produces a strong antibody response among children and adolescents
  • The most adverse reactions were mild or moderate